FloraGen Biosciences
Davis, United StatesFounded 2019
About FloraGen Biosciences
FloraGen Biosciences is a California plant biotechnology startup developing CRISPR-based gene editing tools for cannabis to enable precise modification of cannabinoid profiles and disease resistance traits.
Key Facts
- 1Working on CRISPR-Cas9 protocols specifically optimized for the cannabis genome's unique polyploid structure
- 2Aims to develop cannabis plants with enhanced minor cannabinoid production through targeted gene editing
Frequently Asked Questions
How does CRISPR apply to cannabis?
CRISPR gene editing can precisely modify cannabis DNA to enhance or suppress specific traits like cannabinoid ratios, terpene profiles, disease resistance, or flowering time without introducing foreign genes.
Are gene-edited cannabis plants legal?
Gene-edited plants that do not contain foreign DNA are generally not classified as GMOs in the US, though cannabis-specific regulations vary by state and are still evolving.
Products
- CRISPR gene editing protocols for cannabis
- Trait-modified cannabis plantlets
Specialties
Cannabis gene editingCRISPR cannabinoid pathway engineering
Company Details
- Location
- Davis, United States
- Founded
- 2019
- Publicly Traded
- No
Browse all Technology & Equipment
View more companies in this category
Related Companies
More in United States
Curaleaf Holdings
Wakefield, MA \u2014 Retail & Coffeeshop
Green Thumb Industries
Chicago, IL \u2014 Retail & Coffeeshop
Trulieve Cannabis
Quincy, FL \u2014 Retail & Coffeeshop
Cresco Labs
Chicago, IL \u2014 Producer & Grower